Table 4.

The relationships between the prognostic ARGs and clinicopathological variables.

Gene		Gender		Grade		Stage		T stage		M stage
		Female	Male	G1-2	G3-4	I-II	III-IV	T1-T2	T3-T4	M0	M1
N		166	323	221	268	289	200	306	183	412	77
BID	t-value	1.304		4.847		6.398		5.594		5.132
	P-value	0.193		<0.001		<0.001		<0.001		<0.001
ERBB2	t-value	2.474		4.432		5.506		5.760		2.769
	P-value	0.014		<0.001		<0.001		<0.001		0.006
CASP4	t-value	0.955		4.260		5.335		4.606		4.352
	P-value	0.340		<0.001		<0.001		<0.001		<0.001
PRKCQ	t-value	2.727		1.823		2.170		2.396		0.260
	P-value	0.007		0.069		0.031		0.017		0.795
BAG1	t-value	1.226		4.892		6.110		5.635		4.011
	P-value	0.221		<0.001		<0.001		<0.001		<0.001
INFG	t-value	0.526		4.781		5.255		4.579		4.713
	P-value	0.599		<0.001		<0.001		<0.001		<0.001
ATG16L2	t-value	1.837		0.203		1.467		1.607		0.507
	P-value	0.067		0.839		0.143		0.109		0.612
EIF4EBP1	t-value	0.508		5.484		6.521		5.897		4.502
	P-value	0.611		<0.001		<0.001		<0.001		<0.001
CX3CL1	t-value	3.803		4.427		3.964		4.404		1.663
	P-value	<0.001		<0.001		<0.001		<0.001		0.097
RGS19	t-value	1.168		6.124		5.055		4.237		2.942
	P-value	0.244		<0.001		<0.001		<0.001		0.003
BNIP3	t-value	2.446		3.045		1.969		2.273		0.634
	P-value	0.015		0.003		0.049		0.023		0.526

ARGs, autophagy-related genes; T, tumor invasion; M, metastasis.